Intermittent Fasting Offers No Clear Edge Over Standard Dieting for Weight Loss
A Cochrane review of 22 RCTs finds intermittent fasting produces little to no additional weight loss compared to regular dietary advice or no intervention.
Summary
A 2026 Cochrane systematic review analyzed 22 randomized controlled trials involving 1,995 adults with overweight or obesity to compare intermittent fasting against standard dietary advice or no intervention. The review found that intermittent fasting produced little to no meaningful difference in weight loss, quality of life, or adverse events compared to both comparators. Evidence certainty ranged from low to very low for most outcomes when compared to dietary advice, and moderate when compared to no intervention. No included studies reported participant satisfaction, diabetes status, or comorbidity measures. The authors conclude that individual practicality and sustainability should guide treatment choices, and that longer-term studies beyond 12 months are urgently needed.
Detailed Summary
Obesity and overweight represent a growing global health burden, and dietary interventions remain the cornerstone of management. Intermittent fasting — encompassing time-restricted feeding, periodic fasting, alternate-day fasting, and modified alternate-day fasting — has attracted substantial public and clinical interest as a potentially superior alternative to conventional calorie-restricted diets. This Cochrane review sought to rigorously evaluate that claim.
Researchers searched CENTRAL, MEDLINE, and two clinical trial registries through November 2024, ultimately including 22 randomized controlled trials with 1,995 participants conducted across North America, Australia, China, Europe, and Brazil. All studies were outpatient-based and published between 2016 and 2024. Outcomes of interest included percentage weight loss, achieving a 5% body weight reduction, quality of life, diabetes status, participant satisfaction, and adverse events, assessed at up to 12 months (short-term) and beyond.
When intermittent fasting was compared to regular dietary advice across 21 studies (1,430 participants), the pooled mean difference in percentage weight loss from baseline was -0.33% (95% CI -0.92 to 0.26) — a finding of low certainty due to risk of bias. The probability of achieving a clinically meaningful 5% body weight reduction was virtually identical between groups (RR 0.98, 95% CI 0.82 to 1.18; very low certainty). Quality of life showed a similarly negligible standardized mean difference of 0.11 (95% CI -0.27 to 0.49; low certainty). Adverse events were numerically higher with intermittent fasting but statistically inconclusive (RR 1.45, 95% CI 0.64 to 3.28; very low certainty).
Compared to no intervention or a waiting list across 6 studies (427 participants), intermittent fasting did produce a statistically significant but modest weight loss advantage (MD -3.42%, 95% CI -4.95 to -1.90; moderate certainty). However, this difference was judged as clinically small. Quality of life data came from a single small study and were highly uncertain, and adverse event data from two studies were similarly inconclusive.
Critically, no included studies reported participant satisfaction, changes in diabetes status, or overall comorbidity measures — significant gaps given the metabolic rationale often cited for intermittent fasting. All evidence was limited to 12-month follow-up, leaving long-term effects entirely uncharacterized. The authors recommend that future trials extend follow-up beyond 12 months, enroll diverse populations including those from low- and middle-income countries, and stratify analyses by sex and BMI category to better inform personalized treatment decisions.
Key Findings
- Intermittent fasting produced no clinically meaningful additional weight loss vs. standard dietary advice (MD -0.33%, low certainty).
- Vs. no intervention, intermittent fasting yielded a modest but statistically significant weight loss advantage (MD -3.42%, moderate certainty).
- No significant differences in quality of life were found in either comparison.
- Adverse event rates were numerically higher with IF but results were statistically inconclusive across both comparisons.
- No studies reported participant satisfaction, diabetes status, or comorbidity outcomes — major evidence gaps.
Methodology
This is a Cochrane systematic review and meta-analysis of 22 RCTs (1,995 participants) comparing intermittent fasting to dietary advice or no intervention in adults with overweight or obesity. Risk of bias was assessed using RoB 2; evidence certainty was graded using GRADE. Random-effects models were used for all meta-analyses.
Study Limitations
All included studies were limited to 12-month follow-up, preventing conclusions about long-term effects. Evidence certainty was low to very low for most outcomes due to risk of bias, small sample sizes, and imprecision. Key outcomes including diabetes status, participant satisfaction, and comorbidity measures were unreported across all 22 trials.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.